Carboplatin/Pralatrexate in Recurrent Platinum-Sensitive Ovarian, Fallopian or Primary Peritoneal Cancer

NCT01188876 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Ovarian Cancer
Fallopian Tube Cancer
Peritoneal Cancer

Interventions

DRUG: carboplatin
DRUG: pralatrexate
DRUG: Folic Acid
DRUG: Vitamin B12 Injection

Sponsor

Massachusetts General Hospital

Collaborators

[object Object]
[object Object]
[object Object]